Search for: "Astellas Pharma Inc." Results 41 - 53 of 53
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Oct 2009, 6:05 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
5 Aug 2009, 5:35 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
18 May 2009, 5:24 am
: Omnicare, Inc v OHIM, Astellas Pharma GmbH (Class 46) CFI delivers judgment in case concerning ability of designer who assigns business and related IP to another company, to object when the company tries to register his name as a CTM: Elio Fiorucci v OHIM (IPKat) CFI: Good faith irrelevant when selling non-misleading sausages: Alberto Severi, in his own name and representing Cavazzuti e figli SpA, now known as Grandi Salumifici Italiani SpA v Regione Emilia-Romagna… [read post]
27 Mar 2009, 8:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
1 Dec 2007, 9:00 am
: (Trademark Blog), Short paper on domain name monetization: (Trademark Blog),Comcast puts non-lawyer in charge of IP Strategy: (IAM),Are green technology IP rights owners about to become the new big pharma? [read post]
28 Nov 2007, 8:53 pm
By Sherri Oslick -- Astellas Pharma Inc. of Tokyo, has announced an agreement between its U.S. subsidiary, Astellas U.S. [read post]
26 Nov 2007, 9:02 pm
By Baltazar Gomez -- Last month, Astellas Pharma Inc., King Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd. announced that U.S. subsidiaries of Astellas, along with Item Development AB and King have signed settlement agreements with respect to U.S. [read post]
8 Nov 2007, 9:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]GlobalIP Think Tank top five's: (IP Think Tank),More on IP law in the virtual world: (VirtualLaw), Interesting times for the Citi brand: (IAM), Velcro has won control of the domain name velcro.biz: (OUT-LAW), The Economic Value of Patent 'Trolls': (IP Think Tank),Industry Trilateral group and the 'global patent application' project: (PatentDocs), Update on the BitTorrent war -… [read post]
8 Nov 2007, 8:01 pm
By Sherri Oslick -- Ranbaxy Laboratories, Astellas Pharma US, Inc., and Boehringer Ingelheim Corporation have announced their agreement to enter into a joint stipulation of dismissal without prejudice in their lawsuit over FLOMAX ® (tamsulosin hydrochloride, used to treat benign prostatic hyperplasia). [read post]